* Eikon search string for individual stock moves:
* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh U.S. stock futures were trading flat on Tuesday as investors parsed through the earnings report from JPMorgan Chase and awaited results from Wall Street banks such as Goldman Sachs and Wells Fargo.
At 7:53 ET, Dow e-minis were up 0.16% at 27,385. S&P 500 e-minis were up 0.11% at 3,020.5, while Nasdaq 100 e-minis were up 0.09% at 7,993.75. The top three NYSE percentage gainers premarket: ** Amneal Phrmceuticals Inc, up 5.1% ** Biohaven Pharmaceutical Holding Company Ltd, up 4.9% ** Tata Motors Ltd, up 4.8% The top NYSE percentage losers premarket: ** Turquoise Hill Resources Ltd, down 11.2% ** Celestica Inc, down 7.3% The top three Nasdaq percentage gainers premarket: ** Immuron Ltd, up 115.4% ** Cancer Genetics Inc, up 73.2% ** Aevi Genomic Medicine Inc, up 21.6% The top three Nasdaq percentage losers premarket: ** Tonix Pharmaceuticals Holding Corp, down 34.4% ** Mereo BioPharma Group Plc, down 19.7% ** China Lending Corp, down 19.4% ** Arrow Electronics Inc: down 5.7% premarket BUZZ-Warns on profit following “deteriorating demand” ** J.B. Hunt Transport Services: up 8.2% premarket BUZZ-Rises on Q2 revenue growth ** Cinedigm Corp: up 4.1% premarket BUZZ-Cinedigm eyes best day in 7 months after stock purchase agreement with BEMG ** Goldman Sachs Group: up 1.2% premarket BUZZ-PREVIEW: Goldman Sachs Q2 EPS, revenue expected to drop ** JPMorgan Chase & Co: down 1.5% premarket RPT-BUZZ-PREVIEW: JPMorgan Q2 EPS, Revenue seen rising ** Cancer Genetics Inc: up 73.2% premarket BUZZ-bounces on sale of biopharma business ** Taronis Technologies Inc: up 4.5% premarket BUZZ-Shares jump on plan to spin off gas business ** Aevi Genomic Medicine Inc: up 21.6% premarket BUZZ-Rises after license deal with Astellas to develop rare disease drug ** Tesla Inc: down 1.4% premarket BUZZ-Shares dip as co drops certain variants (Compiled by C Nivedita in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.